Segantii Capital Management’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Segantii Capital Management’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-195,000	Closed	-$2.23M	–	720
2021 Q4	$2.23M	Hold	195,000	–	–	0.07%	131
2021 Q3	$2.19M	Hold	195,000	–	–	0.07%	115
2021 Q2	$2.18M	Hold	195,000	–	–	0.06%	155
2021 Q1	$2.17M	Buy	+195,000	New	+$468K	0.09%	110
2020 Q4	–	Sell	-195,000	Closed	-$1.49M	–	126
2020 Q3	$1.49M	Buy	+195,000	New	+$335K	0.11%	52

Segantii Capital Management's NFH.WS Position: Q1 2022 in Review

Segantii Capital Management sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2022, closing a stake of 195,000 shares — an estimated $2.23M sold.

Segantii Capital Management first reported a position in NFH.WS in Q3 2020 and held it in 5 quarters. The position peaked at $2.23M in Q4 2021. 0 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2022.

Segantii Capital Management reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2022 after selling out during the quarter.
Segantii Capital Management sold 195,000 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2022, an estimated $2.23M.
Segantii Capital Management first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q3 2020 and held it in 5 quarters.
Segantii Capital Management's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $2.23M in Q4 2021.
0 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2022.

Based on Segantii Capital Management's 13F filing for Q1 2022, filed 26 Apr 2022.